Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer
- J. J. Willeumier
- , N. M.A. Van Der Hoeven
- , L. Bollen
- , L. N.A. Willems
- , M. Fiocco
- , Y. M. Van Der Linden
- , P. D.S. Dijkstra
Research output: Contribution to journal › Article › peer-review
12
Citations
(Scopus)